A colloidal oatmeal OTC cream is as clinically effective as a prescription barrier repair cream for the management of mild to moderate atopic dermatitis in African American children

被引：0
|
作者：
Nunez, Christopher [1 ]
Hogan, Daniel [2 ]
Humphrey, Micah [2 ]
Zhang, Paul [1 ]
Lisante, ToniAnne [1 ]
Doshi, Uday [1 ]
机构：
[1] Johnson & Johnson Consumer Co Inc, Morris Plains, NJ USA
[2] Hill Top Res, St Petersburg, FL USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2013年 / 68卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB73 / AB73
页数：1
相关论文
共 33 条
  • [21] Improvement of epidermal barrier function and erythema by cis-urocanic acid emulsion cream in adult patients with mild to moderate atopic dermatitis
    Jansen, Christer T.
    Pylkkanen, Liisa
    Laihia, Jarmo K.
    Peltonen, Juha
    Volanen, Iina
    Leino, Lasse
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S67 - S67
  • [22] Efficacy and tolerance of a barrier cream medical device in association with topical steroids in the management of moderate to severe atopic dermatitis: A randomized controlled trial
    Rossi, Ana Beatris
    Nocera, Therese
    Thouvenin, Marie-Dominique
    Bacquey, Adeline
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB117 - AB117
  • [23] A topical physiologic lipid-based, barrier repair formulation (Epiceram™ cream) is highly-effective monotherapy for moderate-to-severe pediatric atopic dermatitis;: a multicenter, investigator-blinded trial comparing a barrier repair formulation, Epiceram™, to fluticasone proprionate (Cutivate™) cream
    Sugarman, I. L.
    Parish, L. J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S54 - S54
  • [24] Pimecrolimus 1% cream for mild-to-moderate atopic dermatitis: a systematic review and meta-analysis with a focus on children and sensitive skin areas
    Luger, Thomas
    Chu, Chia-Yu
    Elgendy, Ayman
    Ibrahim, Sabeera Begum Binti Kader
    Murashkin, Nikolay
    Ranjan, Sandip
    Zhao, Zuotao
    EUROPEAN JOURNAL OF DERMATOLOGY, 2023, 33 (05) : 474 - 486
  • [25] A daily moisturizer and a steroid-free acute therapy emollient cream reduce the symptoms of atopic dermatitis in babies and children with mild to moderate eczema lesions
    Weber, Teresa M.
    Filbry, Alexander
    Schoelermann, Andrea M.
    Rippke, Frank
    Scherdin, Ulrich
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB60 - AB60
  • [26] EFFICACY AND SAFETY OF ROFLUMILAST CREAM 0.15% IN ADULTS AND CHILDREN AGED 6 AND OLDER WITH MILD TO MODERATE ATOPIC DERMATITIS IN TWO PHASE 3 INTEGUMENT TRIALS
    Simpson, E.
    Eichenfield, L. F.
    Gooderham, M.
    Gonzalez, M.
    Hebert, A. A.
    Papp, K. A.
    Prajapati, V
    Krupa, D.
    Burnett, P.
    Berk, D. R.
    Higham, R.
    VALUE IN HEALTH, 2023, 26 (06) : S40 - S40
  • [27] A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP nonsteroidal cream in the management of mild to moderate atopic dermatitis in infants and children
    Boguniewicz, Mark
    Hebert, Adelaide
    Jarratt, Michael
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB69 - AB69
  • [28] A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial
    Licari, Amelia
    Ruffinazzi, Giulia
    De Filippo, Maria
    Castagnoli, Riccardo
    Marseglia, Alessia
    Agostinis, Fabio
    Puviani, Mario
    Milani, Massimo
    Marseglia, Gian Luigi
    MINERVA PEDIATRICA, 2017, 69 (06) : 470 - 475
  • [29] Skin barrier function and hydration effects of hydrolipid cream alone and in combination in the treatment of mild to moderate atopic dermatitis: Investigator-blinded, split-body, pilot study results
    Kircik, Leon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB67 - AB67
  • [30] Efficacy and safety of roflumilast cream 0.15% in adults and children aged=6 years with mild to moderate atopic dermatitis in two phase 3 trials (INTEGUMENT-1 and INTEGUMENT-2)
    Simpson, Eric
    Eichenfield, Lawrence
    Gooderham, Melinda
    Gonzalez, Mercedes E.
    Hebert, Adelaide
    Papp, Kim
    Prajapati, Vimal
    Krupa, David
    Burnett, Patrick
    Berk, David
    Higham, Robert
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
1234